Showing results (111-120 of 500) with videos related to
Sort By:
Pageof 50
European Journal of Immunology|March 21, 2014
Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive functionMelanie Stumpf, Xuyu Zhou, Shunsuke Chikuma, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
Insight into the mechanism of TCR-V beta 8+/CD8+ T cell-mediated MOPC-315 tumor eradicationM B Mokyr, A Prokhorova, M Rubin, et al.The Journal of Clinical Investigation|May 19, 2015
T cells in the control of organ-specific autoimmunityJeffrey A Bluestone, Hélène Bour-Jordan, Mickie Cheng, et al.Optics Express|May 8, 2009
Three-dimensional optical tomography of hemodynamics in the human headA Bluestone, G Abdoulaev, C Schmitz, et al.Annual Review of Cell and Developmental Biology|January 1, 1995
TCR gamma delta cells: a specialized T-cell subset in the immune systemJ A Bluestone, R Khattri, R Sciammas, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cellsM Donepudi, P Raychaudhuri, J A Bluestone, et al.Cancer Research|December 16, 1998
Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing miceM B Mokyr, T Kalinichenko, L Gorelik, et al.Plos One|June 7, 2013
DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stabilityLukas T Jeker, Xuyu Zhou, Robert Blelloch, et al.Frontiers in Immunology|May 8, 2023
Opportunities for Treg cell therapy for the treatment of human diseaseJeffrey A Bluestone, Brent S McKenzie, Joshua Beilke, et al.Science (New York, N.Y.)|October 28, 1988
In vivo administration of anti-CD3 prevents malignant progressor tumor growthJ D Ellenhorn, R Hirsch, H Schreiber, et al.Pageof 50